SINGER NICHOLAS JASON enters ERNEXA THERAPEUTICS INC. with 2.10M shares across direct and indirect positions
This filing by SINGER NICHOLAS JASON establishes the baseline for all future Form 4 insider transaction reports at ERNEXA THERAPEUTICS INC..
Indirect
Filed: 6/7/2022ACC: 0001140361-22-022255
Director
Since Mar 2021
2.10M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
2
Security positions
2.10M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned1.07M
Common Stock
IndirectShares owned1.02M
Total
2.10M indirect2.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.07M | Indirect |
| Common Stock | 1.02M | Indirect |
| Total | 2.10M | 2.10M indirect |
Derivative Holdings0
No derivative holdings reported